Hanlon Investment Management, Inc. Pfizer Inc Transaction History

Hanlon Investment Management, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $188,660 - $216,642	7,287 New	7,287 $202,000
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $168,503 - $219,962	4,036 New	4,036 $0
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $182,723 - $216,652	3,927 New	3,927 $206,000
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $155,824 - $193,086	-3,406 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$41.32 - $61.25 $140,735 - $208,617	3,406 New	3,406 $201,000
Q3 2021 Nov 19, 2021	SELL	$39.25 - $50.42 $306,110 - $393,225	-7,799 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $88,374 - $100,113	-2,461 Reduced 23.99%	7,799 $305,000
Q1 2021 Apr 16, 2021	BUY	$33.49 - $37.77 $1,507 - $1,699	45 Added 0.44%	10,260 $372,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $6,024 - $7,660	-180 Reduced 1.73%	10,215 $376,000
Q3 2020 Nov 17, 2020	BUY	$31.75 - $37.25 $10,160 - $11,920	320 Added 3.18%	10,395 $381,000
Q2 2020 Jul 21, 2020	BUY	$30.12 - $36.54 $1,144 - $1,388	38 Added 0.38%	10,075 $329,000
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $2,892 - $4,132	-107 Reduced 1.05%	10,037 $328,000
Q4 2019 Jan 16, 2020	BUY	$32.92 - $37.36 $1,119 - $1,270	34 Added 0.34%	10,144 $397,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $326,102 - $422,858	-10,037 Reduced 49.82%	10,110 $363,000
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $24,258 - $27,237	656 Added 3.37%	20,147 $873,000
Q1 2019 Jul 02, 2019	BUY	$37.5 - $41.2 $730,912 - $803,029	19,491 New	19,491 $828,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hanlon Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hanlon Investment Management, Inc. with notifications on news.